Literature DB >> 27265011

Interleukin-10 and interferon-gamma cytokine gene polymorphisms may be risk factors for chronic myelogenous leukemia.

Bilkay Baştürk, Elif Evke, Ahmet Tunalı, Sema Karakuş.   

Abstract

We investigated the association of cytokine gene polymorphisms with the development of chronic myelogenous leukemia (CML) and whether there is an association between gene polymorphisms Th1 and Th2 or regulatory- type cytokines and CML. Thirty patients with CML and 60 healthy controls were enrolled in this study. All genotyping (TNF-α, TGF-β, IL-10, IL-6, and IFN-γ) studies were performed using sequence-specific primers PCR (PCR-SSP). Frequencies of IL-10 (-1082, -819, -592) GCC/ATA (p= 0.009) and IFN-γ; +874 T/A (p= 0.037) polymorphisms were significantly greater in the patients with CML. In contrast, significantly lower frequencies of the IFN-γ A/A (p= 0.004) genotype were observed in patients with CML compared with controls. The results suggest that the IL-10 GCC/ATA and IFN-γ T/A polymorphisms are potential risk factors, and that the IFN-γ A/A polymorphism is a protective factor, for CML in this study group.

Entities:  

Year:  2005        PMID: 27265011

Source DB:  PubMed          Journal:  Turk J Haematol        ISSN: 1300-7777            Impact factor:   1.831


  3 in total

1.  Lack of association between interferon gamma +874 T/A polymorphism and cancer risk: an updated meta-analysis.

Authors:  Yu-Zheng Ge; Yi-Dan Wang; Zheng Xu; Lu-Wei Xu; Ya-Ping Wang; Mao-Hong Gu; Ai-Xing Ding; Xian-Bo Zhu; Ran Wu; Wen-Cheng Li; You-Di Xu; Rui-Peng Jia
Journal:  Tumour Biol       Date:  2014-03-28

Review 2.  Association of Interferon Gamma +874T/A Polymorphism and Leukemia Risk: A Meta-Analysis.

Authors:  Zhitong Wu; Yifan Sun; Shengbo Zhu; Shifu Tang; Chunming Liu; Wenzhou Qin
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

3.  The single nucleotide polymorphisms of interleukin-10 are associated with the risk of leukaemia: Evidence from 18 case-control studies.

Authors:  Shupei Gao; Kun Tang; Jinqing Chen; Jianmiao Wang
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.